54.20BMarket Cap8.34P/E (TTM)
4.630High4.510Low60.52MVolume4.550Open4.550Pre Close277.44MTurnover0.51%Turnover Ratio8.37P/E (Static)11.86BShares7.27052wk High1.42P/B54.20BFloat Cap4.48052wk Low0.14Dividend TTM11.86BShs Float12.859Historical High0.281Dividend LFY2.64%Amplitude-1.639Historical Low4.584Avg Price2000Lot Size3.06%Div YieldTTM6.15%Div Yield LFY
CSPC PHARMA Stock Forum
December 22, 2023
2142.HK
1.56
(-2.5%)
The biopharma company has marked out a path to profitability by licensing its drug expertise and antibody platforms to partners such as Pfizer
Key Takeaways:
Nona Biosciences, a subsidiary of HBM Holdings, has struck a licensing-out deal with a Pfizer-owned biotech for an initial sum of $53 million and milestone payments of up to $1.05 billion
HBM Holdin...
The Central Economic Work Conference proposed to meet reasonable financing needs of real estate enterprises of different ownerships equally. Chinese developers rose this morning before dropping yesterday (12th). $LONGFOR GROUP (00960.HK)$ and ...
There was HKD268.3 million and HKD166.3 million Southbound Trading net outflow from $TENCENT (00700.HK)$ and $CNOOC (00883.HK)$ .
For $SH->HK Connect (GangGuTong)$ , $CSPC PHARMA (01093.HK)$ was the most active stock with highest net inflow of HKD145.5 ...
Techs slid as the market continued to be watchful of the Sino-US relations:
$BABA-W (09988.HK)$ dived 3.2% to $84.1.
$TENCENT (00700.HK)$ sank 1.9% to $338.4.
$MEITUAN-W (03690.HK)$ , $XIAOMI-W (01810.HK)$ , ...
No comment yet